Literature DB >> 19740347

Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms.

Kan Shida1, Junko Kiyoshima-Shibata, Rumi Kaji, Masato Nagaoka, Masanobu Nanno.   

Abstract

We previously showed that Lactobacillus strains having a rigid cell wall resistant to intracellular digestion can stimulate macrophages to induce large a quantity of interleukin-12 (IL-12). In this study, we examined the influence of lactobacilli and bacterial cell wall components on IL-12 production by macrophages that was induced by Lactobacillus casei, which has a rigid cell wall. Easily digestible lactobacilli such as Lactobacillus johnsonii and Lactobacillus plantarum or their intact cell walls (ICWs) weakly or very weakly induced IL-12 production by macrophages, and inhibitedL. casei-induced IL-12 production. While the ICW of L. casei was resistant to intracellular digestion and did not inhibit L. casei-induced IL-12 production, its polysaccharide-depleted ICW, i.e. intact peptidoglycan, was sensitive to intracellular digestion and inhibited L. casei-induced IL-12 production. Furthermore, the peptidoglycans of L. johnsonii, L. plantarum and Staphylococcus aureus also inhibited L. casei-induced IL-12 production. Peptidoglycans from lactobacilli suppressed L. casei-induced expression of IL-12p40 but not IL-12p35 mRNA. Inhibition of IL-12 production by peptidoglycan was mitigated in Toll-like receptor 2 (TLR2)-deficient macrophages compared with the inhibition in wild-type macrophages. A derivative of the minimal structural unit of peptidoglycan (6-O-stearoyl-muramyl dipeptide) recognized by nucleotide-binding oligomerization domain 2 (NOD2) could also suppress L. casei-induced IL-12 production. These findings demonstrate that easily digestible bacteria and peptidoglycan suppress IL-12 production through pattern recognition receptors such as TLR2 and NOD2. IL-12 production in the gut may be negatively regulated by the simultaneous inhibitory actions of various resident bacteria that are susceptible to intracellular digestion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740347      PMCID: PMC2753894          DOI: 10.1111/j.1365-2567.2009.03095.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  How microorganisms tip the balance between interleukin-12 family members.

Authors:  Stanislas Goriely; Markus F Neurath; Michel Goldman
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

2.  MyD88 but not TLR2, 4 or 9 is essential for IL-12 induction by lactic acid bacteria.

Authors:  Shintaro Ichikawa; Rei Fujii; Daisuke Fujiwara; Yutaka Komiyama; Tsuneyasu Kaisho; Masahiro Sakaguchi; Yutaka Konishi
Journal:  Biosci Biotechnol Biochem       Date:  2007-12-07       Impact factor: 2.043

Review 3.  Probiotics and immunology: separating the wheat from the chaff.

Authors:  Kan Shida; Masanobu Nanno
Journal:  Trends Immunol       Date:  2008-11       Impact factor: 16.687

4.  Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression.

Authors:  Kirsten A Baken; Janine Ezendam; Eric R Gremmer; Arja de Klerk; Jeroen L A Pennings; Bianca Matthee; Ad A C M Peijnenburg; Henk van Loveren
Journal:  Int J Food Microbiol       Date:  2006-07-26       Impact factor: 5.277

5.  Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin.

Authors:  Z M Wang; C Liu; R Dziarski
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

6.  Characterisation of Eubacterium cell wall: peptidoglycan structure determines arthritogenicity.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

7.  Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells.

Authors:  Louise Hjerrild Zeuthen; Lisbeth Nielsen Fink; Hanne Frøkiaer
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

8.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

Authors:  Tomohiro Watanabe; Naoki Asano; Peter J Murray; Keiko Ozato; Prafullakumar Tailor; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 9.  Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions.

Authors:  Christopher Weidenmaier; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2008-03-10       Impact factor: 60.633

Review 10.  Myeloid C-type lectins in innate immunity.

Authors:  Matthew J Robinson; David Sancho; Emma C Slack; Salomé LeibundGut-Landmann; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

View more
  40 in total

Review 1.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

Review 2.  Characterization and function of membrane vesicles in Gram-positive bacteria.

Authors:  Yina Cao; Huancai Lin
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-06       Impact factor: 4.813

3.  Probiotic Potential of a Lactobacillus Bacterium of Canine Faecal-Origin and Its Impact on Select Gut Health Indices and Immune Response of Dogs.

Authors:  Sachin Kumar; Ashok Kumar Pattanaik; Shalini Sharma; Sunil Eknath Jadhav; Narayan Dutta; Avneesh Kumar
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

Review 4.  Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective.

Authors:  Francesca Turroni; Marco Ventura; Ludovica F Buttó; Sabrina Duranti; Paul W O'Toole; Mary O'Connell Motherway; Douwe van Sinderen
Journal:  Cell Mol Life Sci       Date:  2013-03-21       Impact factor: 9.261

5.  In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.

Authors:  Valentina Taverniti; Mario Minuzzo; Stefania Arioli; Ilkka Junttila; Sanna Hämäläinen; Hannu Turpeinen; Diego Mora; Matti Karp; Marko Pesu; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

6.  Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway.

Authors:  Tomoyuki Shimazu; Julio Villena; Masanori Tohno; Hitomi Fujie; Shoichi Hosoya; Takeshi Shimosato; Hisashi Aso; Yoshihito Suda; Yasushi Kawai; Tadao Saito; Seiya Makino; Shuji Ikegami; Hiroyuki Itoh; Haruki Kitazawa
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

7.  Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia.

Authors:  Monica M Holley; Yongqing Zhang; Elin Lehrmann; William H Wood; Kevin G Becker; Tammy Kielian
Journal:  Glia       Date:  2011-09-07       Impact factor: 7.452

8.  Assessment of Lactobacillus gasseri as a candidate oral vaccine vector.

Authors:  Laura Stoeker; Shila Nordone; Sara Gunderson; Lin Zhang; Akinobu Kajikawa; Alora LaVoy; Michael Miller; Todd R Klaenhammer; Gregg A Dean
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

9.  Inclusion of chicory (Cichorium intybus L.) in pigs' diets affects the intestinal microenvironment and the gut microbiota.

Authors:  Haoyu Liu; Emma Ivarsson; Johan Dicksved; Torbjörn Lundh; Jan Erik Lindberg
Journal:  Appl Environ Microbiol       Date:  2012-04-06       Impact factor: 4.792

10.  Mechanisms of Action of Probiotics.

Authors:  Julio Plaza-Diaz; Francisco Javier Ruiz-Ojeda; Mercedes Gil-Campos; Angel Gil
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.